🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/10/2007 | 20,96 | 21,75 | 20,59 | 21,63 | +3,77% | 5,54% | 359.286 |
| 08/10/2007 | 20,55 | 20,85 | 20,21 | 20,85 | +1,64% | 3,10% | 79.856 |
| 05/10/2007 | 20,40 | 20,92 | 20,06 | 20,51 | +1,86% | 4,22% | 209.111 |
| 04/10/2007 | 20,70 | 20,77 | 20,03 | 20,14 | -2,54% | 3,62% | 292.601 |
| 03/10/2007 | 20,40 | 20,96 | 20,32 | 20,66 | +0,18% | 3,12% | 102.699 |
| 02/10/2007 | 20,55 | 20,77 | 20,40 | 20,62 | +0,92% | 1,82% | 69.650 |
| 01/10/2007 | 19,91 | 20,44 | 19,84 | 20,44 | +2,25% | 3,01% | 97.516 |
| 28/09/2007 | 20,59 | 20,89 | 19,88 | 19,99 | -3,26% | 4,91% | 104.061 |
| 27/09/2007 | 21,04 | 21,11 | 20,03 | 20,66 | -0,54% | 5,16% | 86.001 |
| 26/09/2007 | 20,55 | 21,07 | 20,47 | 20,77 | +2,02% | 2,91% | 97.516 |
| 25/09/2007 | 20,77 | 21,22 | 20,32 | 20,36 | -2,86% | 4,32% | 290.490 |
| 24/09/2007 | 21,97 | 22,12 | 20,92 | 20,96 | -4,76% | 5,45% | 222.363 |
| 21/09/2007 | 21,60 | 22,12 | 21,37 | 22,01 | +2,80% | 3,47% | 550.443 |
| 20/09/2007 | 21,90 | 22,27 | 21,07 | 21,41 | -3,05% | 5,47% | 99.520 |
| 19/09/2007 | 22,27 | 22,46 | 22,01 | 22,08 | +0,34% | 2,02% | 119.744 |
| 18/09/2007 | 21,48 | 22,42 | 20,96 | 22,01 | +2,62% | 6,79% | 195.646 |
| 17/09/2007 | 22,35 | 22,79 | 21,37 | 21,45 | -4,50% | 6,37% | 84.799 |
| 14/09/2007 | 22,08 | 22,46 | 21,71 | 22,46 | +1,01% | 3,39% | 101.871 |
| 13/09/2007 | 22,46 | 22,50 | 21,93 | 22,23 | -0,67% | 2,50% | 406.414 |
| 12/09/2007 | 22,46 | 22,53 | 22,05 | 22,38 | -0,50% | 2,17% | 532.704 |
| 11/09/2007 | 22,31 | 22,50 | 22,08 | 22,50 | +1,18% | 1,85% | 319.611 |
| 10/09/2007 | 22,87 | 22,91 | 21,56 | 22,23 | -2,30% | 5,89% | 235.507 |
| 07/09/2007 | 23,13 | 23,21 | 22,46 | 22,76 | -2,41% | 3,24% | 274.487 |
| 06/09/2007 | 23,21 | 23,36 | 22,91 | 23,32 | +0,65% | 1,94% | 245.900 |
| 05/09/2007 | 23,54 | 23,58 | 22,87 | 23,17 | -2,21% | 3,02% | 471.362 |
| 04/09/2007 | 23,58 | 23,92 | 23,43 | 23,69 | +0,96% | 2,06% | 179.963 |
| 31/08/2007 | 23,73 | 23,99 | 23,43 | 23,47 | +0,16% | 2,37% | 208.363 |
| 30/08/2007 | 22,61 | 23,88 | 22,31 | 23,43 | +2,79% | 6,95% | 138.900 |
| 29/08/2007 | 22,68 | 22,98 | 22,01 | 22,79 | +2,01% | 4,29% | 122.603 |
| 28/08/2007 | 22,98 | 23,13 | 21,75 | 22,35 | -3,40% | 6,03% | 146.434 |